- Home
- Media Center
- Press releases
- Innovative Medicine
Innovative Medicine
Interleukin-6 Inhibitor Sirukumab (CNTO 136) Phase 2 Data Show Promise In The Treatment Of Active Rheumatoid Arthritis
Sirukumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis in Patients with Active Disease Despite Treatment with Methotrexate
New Four Year STELARA™* Data Show Consistent Safety Profile Over Time In Patients With Moderate To Severe Plaque Psoriasis
Results Presented from the STELARA™ Clinical Development Program Also Demonstrate Consistency of Response across Multiple Ethnic Populations
Veridex Launches CELLTRACKS® Circulating Melanoma Cell Kit For Research Use
Automated process gives researchers a simple, reliable method to capture and count circulating melanoma cells
FDA Approves EDURANT™ (rilpivirine) For Use in Treatment-Naïve Adults with HIV-1
Third medication for Tibotec Therapeutics HIV treatment portfolio
Phase 2b Data Show Treatment With STELARA® Induced and Maintained Clinical Response in Patients With Moderate to Severe Crohn’s Disease
Study Findings Show Efficacy of STELARA in Patients Who Previously Had Inadequate Response to Tumor Necrosis Factor Antagonists
New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis
Study Findings Demonstrate Clinical Response with REMICADE in Pediatric Patients Who Have Not Responded to Conventional Therapy
“Living with Schizophrenia” Documentary Shines Spotlight on People with Schizophrenia: A Misunderstood and Stigmatized Illness
Film provides powerful insights through compelling first-person life stories